Company intelligence / Profile preview

Maks Drug Ltd.

Ownership: Private
Employees: ~150
Development stage: Commercial

Overview

Maks Drug Ltd. manufactures and distributes a diverse selection of generic pharmaceuticals, serving both short-term and long-term health needs with an emphasis on quality standards. The company aims for significant growth within Bangladesh's pharmaceutical sector.[1][3]

Therapeutic areas: Other
Modalities: Generic small molecules
Industry: Biotech

Drug pipeline

6 assets

Cadiar-D

5 more assets in the full pipeline.

Partnerships

Not specified in available sources.

Beyond the preview

Go deeper on Maks Drug Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maks Drug Ltd..